Skip to main content
SpringerLink
Log in

Comparative Tolerability Profile of Hypertensive Crisis Treatments

  • Review Article
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Hypertensive crisis is defined as a severe elevation in BP and is classified as either urgency or emergency. In hypertensive urgency there is no end-organ injury and no evidence that acute BP lowering is beneficial. Indeed, rapid uncontrolled pressure reduction may be harmful. Therefore, in hypertensive urgencies BP should be lowered gradually over 24 to 48 hours using oral antihypertensives.

When the cause of transient BP elevations is easily identified, appropriate treatment should be given. When the cause is unknown, an oral antihypertensive should be given. The efficacy of available treatments appear similar; however, the underlying pathophysiological and clinical findings, mechanism of action and potential for adverse effects should guide choice. Captopril should be avoided in patients with bilateral renal artery stenosis or unilateral renal artery stenosis in patients with a solitary kidney. Nifedipine and other dihydropyridines increase heart rate whereas Clonidine, β-blockers and labetalol tend to decrease it. This is particularly important in patients with ischaemic heart disease. Labetalol and β-blockers are contraindicated in patients with bronchospasm and bradycardia or heart blocks. Clonidine should be avoided if mental acuity is desired.

In hypertensive emergency there is an immediate threat to the integrity of the cardiovascular system. BP should be immediately reduced to avoid further end organ damage. Sodium nitroprusside is the most popular agent. Nitroglycerin (glyceryl trinitrate) is preferred when there is acute coronary insufficiency. A β-blocker may be added in some patients. Loop diuretics, nitroglycerin and sodium nitroprusside are effective in patients with concomitant pulmonary oedema. Enalaprilat is also theoretically helpful, especially when the renin system might be activated. Initial treatment of aortic dissection involves rapid, controlled titration of arterial pressure to normal levels using intravenous sodium nitroprusside and a β-blocker. If β-blockers are contraindicated, Urapidil or trimetaphan camsilate are alternatives. Hydralazine is the drug of choice for patients with eclampsia. Labetalol, Urapidil or calcium antagonists are possible alternatives if hydralazine fails or is contraindicated. For patients with catecholamine-induced crises, an α-blocker such as phentolamine should be given; labetalol or sodium nitroprusside with β-blockers are alternatives.

There are few, if any, comparative or randomised trials providing definitive conclusions about the efficacy and safety of comparative agents. Some investigators recommend decreasing the diastolic BP to no less than 100 to 110mm Hg. A reasonable approach for most patients with hypertensive emergencies is to lower the mean arterial pressure by 25% over the initial 2 to 4 hours with the most specific antihypertensive regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med 1990; 323: 1177–83

    Article  PubMed  CAS  Google Scholar 

  2. The Fifth Report of the Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993; 153: 154–83

    Article  Google Scholar 

  3. Zampaglione B, Pascale C, Marchisio M. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension 1996; 27: 144–7

    Article  PubMed  CAS  Google Scholar 

  4. Kaplan NM. Management of hypertensive emergencies. Lancet 1994; 344: 1333–8

    Article  Google Scholar 

  5. Varon J, Fromm Jr RE. Hypertensive crises: the need for urgent management. Postgrad Med 1996; 99: 189-91, 195-6, 199-200 & 203

    Google Scholar 

  6. McKindley DS, Boucher BA. Advances in pharmacotherapy: treatment of hypertensive crisis. J Clin Pharm Ther 1994; 19: 163–80

    Article  PubMed  CAS  Google Scholar 

  7. Phillips RA, Krakoff LR. Topics in hypertension: hypertensive emergencies, true and false. American Society of Hypertension 1997; 3-10

  8. Kaplan NM. Hypertensive crises in clinical hypertension. In: Kaplan NM, editor. Clinical Hypertension. Maryland: Williams and Wilkins, 1995; 281–97

    Google Scholar 

  9. Cetnarowski AB, Conti DR. Nitroprusside toxicity and low-dose infusion. Ann Intern Med 1986; 104: 895–6

    PubMed  CAS  Google Scholar 

  10. Robin ED, McCauley R. Nitroprusside-related cyanide poisoning. Time (long past due) for urgent, effective interventions. Chest 1992; 102: 1842–5

    Article  PubMed  CAS  Google Scholar 

  11. Sarvotham SS. Nitroprusside therapy in post-open heart hypertensives [letter]. Aritual tryst with cyanide death? Chest 1987; 91: 796

    PubMed  CAS  Google Scholar 

  12. Patel CB, Laboy V, Venus B, et al. Use of sodium nitroprusside in post-coronary bypass surgery. A plea for conservatism. Chest 1986; 89: 663–7

    Article  PubMed  CAS  Google Scholar 

  13. Abdelwahab W, Frishman W, Landau A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol 1995; 35: 747–62

    PubMed  CAS  Google Scholar 

  14. Nightingale SL. From the Food and Drug Administration. New labeling for sodium nitroprusside emphasizes risk of cyanide toxicity. JAMA 1991; 265: 847

    Article  PubMed  CAS  Google Scholar 

  15. Dabney BJ, Zelamey PT, Hall AH. Evaluation and treatment of patients exposed to systemic asphyxiants. Emerg Care Q 1990; 6: 65–80

    Article  Google Scholar 

  16. Kaplan JA, Jones EL. Vasodilator therapy during coronary artery surgery. Comparison of nitroglycerin and nitroprusside. J Thorac Cardiovasc Surg 1979; 77: 301–9

    PubMed  CAS  Google Scholar 

  17. Flaherty JT, Magee PA, Gardner TL, et al. Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery. Circulation 1982; 65: 1072–7

    Article  PubMed  CAS  Google Scholar 

  18. Fremes SE, Weisel RD, Mickle DAG, et al. A comparison of nitroglycerin and nitroprusside in the treatment of postoperative hypertension. Ann Thorac Surg 1985; 39: 53–60

    Article  PubMed  CAS  Google Scholar 

  19. Reisin E, Huth MM, Nguyen BP Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension. Hypertension 1990; 13 Suppl.: 59–62

    Article  Google Scholar 

  20. Gretler DD, Elliott WJ, Moscucci M. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam. Arch Intern Med 1992; 152: 2445–8

    Article  PubMed  CAS  Google Scholar 

  21. Deal JE, Barratt TM. Dillon MJ. Management of hypertensive emergencies. Arch Dis Child 1992; 67: 1089–92

    Article  PubMed  CAS  Google Scholar 

  22. Hirschl MM, Binder M, Bur A, et al. Safety and efficacy of Urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intens Care Med 1997; 23: 885–8

    Article  CAS  Google Scholar 

  23. van der Stroom JG, van Wezel HB, Vergroesen I, et al. Comparison of the effects of Urapidil and sodium nitroprusside on haemodynamic state, myocardial metabolism and function in patients during coronary artery surgery. Br J Anaesth 1996; 76: 645–51

    Article  PubMed  Google Scholar 

  24. Turner JM, Powell D, Gibson RM, et al. Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan. Br J Anaesth 1977; 49: 419–25

    Article  PubMed  CAS  Google Scholar 

  25. Gifford Jr RW. Management of hypertensive crises. JAMA 1991; 266: 829–35

    Article  PubMed  Google Scholar 

  26. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Engl J Med 1992; 326: 927–32

    Article  PubMed  CAS  Google Scholar 

  27. Kaplan JA, Dunbar RW, Jones EL. Nitroglycerin infusion during coronary artery surgery. Anesthesiology 1976; 45: 14–21

    Article  PubMed  CAS  Google Scholar 

  28. Snyder SW, Wheeler AS, James FM. The use of nitroglycerin to control severe hypertension of pregnancy during cessarian section. Anesthesiology 1979; 51: 563–4

    Article  PubMed  CAS  Google Scholar 

  29. Charash B, Scheidt S. Nitroglycerin. In: Messerli FH, editor. Cardiovascular drug therapy. Philadelphia: WB. Saunders, 1990: 871–80

    Google Scholar 

  30. Bussmann WD, Kenedi P, von Mengden HJ. Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension. Clin Invest 1992; 70: 1085–8

    Article  CAS  Google Scholar 

  31. Cottrell JE, Turndorf H. Intravenous nitroglycerin. Am Heart J 1978; 96: 550–3

    Article  PubMed  CAS  Google Scholar 

  32. Barry DI, Strandgaard S, Graham DI, et al. Effect of diazoxide-induced hypotension on cerebral blood flow in hypertensive rats. Eur J Clin Invest 1983; 13: 201–7

    Article  PubMed  CAS  Google Scholar 

  33. Kumar GK, Dastoor FC, Robayo JR, et al. Side effects of diazoxide. JAMA 1976; 235: 275–6

    Article  PubMed  CAS  Google Scholar 

  34. Hirschl MM. Guidelines for the drug treatment of hypertensive crises. Drugs 1995; 50: 991–1000

    Article  PubMed  CAS  Google Scholar 

  35. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenous given hydralazine bolus. Surg Gynecol Obstet 1985; 161: 240–4

    PubMed  CAS  Google Scholar 

  36. Lunell NO, Lewander R, Nylund L, et al. Acute effect of dihydralazine on uteroplacental blood flow in hypertension during pregnancy. Gynecol Obstet Invest 1983; 16: 274–82

    Article  PubMed  CAS  Google Scholar 

  37. Clifton GG, Cook ME, Bienvenu GS, et al. Intravenous nicardipine in severe systemic hypertension. Am J Cardiol 1989; 64(15): 16H–18H

    Article  PubMed  CAS  Google Scholar 

  38. Rousseau MF, Etienne J, Van Mechelen H, et al. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol 1984; 6: 833–9

    Article  PubMed  CAS  Google Scholar 

  39. Lambert CR, Hill JA, Nichols WW, et al. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 1985; 55: 652–6

    Article  PubMed  CAS  Google Scholar 

  40. Wallin JD, Fletcher E, Rain VS, et al. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial. Arch Intern Med 1989; 149: 2662–9

    Article  PubMed  CAS  Google Scholar 

  41. Floyd J, Komer C, Frishman W Treatment of acute hypertension post-coronary artery bypass grafting with intravenous nicardipine [abstract]. Crit Care Med 1989; 17: S11

    Article  Google Scholar 

  42. Halpern N, Slader R, Goldberg J, et al. Nicardipine infusion for postoperative hypertension after surgery of the head and neck. Crit Care Med 1990; 18: 950–5

    Article  PubMed  CAS  Google Scholar 

  43. Intravenous Nicardipine Study group. Efficacy and safety of intravenous nicardipine in the control of postoperative hypertension. Chest 1991; 99: 393–8

    Article  Google Scholar 

  44. Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 1992; 20(12): 1637–43

    Article  PubMed  CAS  Google Scholar 

  45. Clifton GG, Wallin JD. Intravenous nicardipine: an effective new agent for the treatment of severe hypertension. Angiology 1990; 41: 1005–9

    PubMed  CAS  Google Scholar 

  46. David D, Dubois C, Loria Y. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. J Cardiothoracic Vasc Anesth 1991; 5: 357–61

    Article  CAS  Google Scholar 

  47. Wong MCW. Haley EC Jr. Calcium antagonists: stroke therapy coming of age. Stroke 1990; 21: 494–501

    Article  PubMed  CAS  Google Scholar 

  48. Tettenborn D, Dycka J. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 1990; 21 Suppl. IV: 85–9

    Google Scholar 

  49. Grossman E, Oren S, Messerli FH. Isradipine. In: Messerli FH, editor. Cardiovascular drug therapy. Philadelphia: W. B. Saunders, 1996: 1016–24

    Google Scholar 

  50. Saragoca MA, Mulinari RA, Oliveira AP, et al. Parenteral isradipine reduces blood pressure in hypertensive crisis. Am J Hypertens 1993; 6 Suppl.: 112S–114S

    PubMed  CAS  Google Scholar 

  51. McDonald AJ, Yealy DM, Jacobsen S. Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED. Am J Emerg Med 1993; 11: 460–3

    Article  PubMed  CAS  Google Scholar 

  52. Dunn FG, Oigman W, Messerli FH, et al. Hemodynamic effects of intravenous labetalol in essential hypertension. Clin Pharmacol Ther 1983; 33: 139–43

    Article  PubMed  CAS  Google Scholar 

  53. Huey J, Thomas JP, Hendricks DR, et al. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency. Am J Hypertens 1988; 1: 284S–289S

    PubMed  CAS  Google Scholar 

  54. Cressman MD, Vidt DG, Gifford RW Jr, et al. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies. Am Heart J 1984; 107: 980–5

    Article  PubMed  CAS  Google Scholar 

  55. Wilson DJ, Wallin JD, Vlachakis ND, et al. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med 1983; 75: 95–102

    Article  PubMed  CAS  Google Scholar 

  56. Morel DR, Forster A, Suter PM. Intravenous labetalol in the treatment of hypertension following coronary artery surgery. Br J Anaesth 1982; 54: 1191–6

    Article  PubMed  CAS  Google Scholar 

  57. Leslie JB, Kalayjian RW, Sirgo MA, et al. Intravenous labetalol for treatment of postoperative hypertension. Anesthesiology 1987; 67: 413–6

    Article  PubMed  CAS  Google Scholar 

  58. Mabie WC, Gonzalez AR, Sibai BM, et al. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987; 70: 328–33

    PubMed  CAS  Google Scholar 

  59. Hirschl MM, Seidler D, Zeiner A, et al. Intravenous Urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies. Am J Emerg Med 1993; 11: 653–6

    Article  PubMed  CAS  Google Scholar 

  60. Giuntoli F, Gabbani S, Natali A, et al. Treatment of hypertensive emergencies with Urapidil. Curr Ther Res 1991; 49: 296–9

    Google Scholar 

  61. Langtry HD, Mammen GJ, Sorkin EM. Urapidil: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 1989; 38: 900–40

    Article  PubMed  CAS  Google Scholar 

  62. Fontana F, Allaria B, Brunetti B, et al. Cardiac and circulatory response to the intravenous administration of Urapidil during general anaesthesia. Drugs Under Exp Clin Res 1990; 16: 315–8

    CAS  Google Scholar 

  63. Zakowski M, Kaufman B, Verguson P, et al. Esmolol use during resection of pheochromocytoma: report of three cases. Anesthesiology 1989; 70: 875–7

    Article  PubMed  CAS  Google Scholar 

  64. Mohindra SK, Udeanl GO. Intravenous esmolol in acute aortic dissection. Ann Pharmacother 1991: 25: 735–8

    CAS  Google Scholar 

  65. Fenner SG, Mahoney A, Cashman JN. Repair of traumatic transection of the thoracic aorta: esmolol for intraoperative control of arterial pressure. Br J Anaesth 1991: 67: 483–7

    Article  PubMed  CAS  Google Scholar 

  66. Mihm FG, Sandhu JS, Brown MD, et al. Short-acting beta-adrenergic blockade as initial drug therapy on pheochromocytoma. Crit Care Med 1990; 18: 673–4

    Article  PubMed  CAS  Google Scholar 

  67. Savi L, Montebelli MR, Mazza A, et al. A new therapy for hypertensive emergencies: intravenous Captopril. A preliminary report. Curr Ther Res 1990; 47: 1073–81

    Google Scholar 

  68. Gavras H. The role of angiotensin converting enzyme inhibitors in the management of urgent hypertensive situations: a review. Cardiovasc Drug Rev 1992; 10: 117–24

    Article  Google Scholar 

  69. Postma CT, Dennesen PJW, de Boo T, et al. First dose hypotension after Captopril: can it be predicted? A study of 240 patients. J Hum Hypertens 1992; 6: 205–9

    PubMed  CAS  Google Scholar 

  70. Saunders E, Weir MR, Kong BW, et al. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990; 150: 1707–13

    Article  PubMed  CAS  Google Scholar 

  71. Hirschl MM, Binder M, Bur A, et al. Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises. Arch Intern Med 1995; 155: 2217–23

    Article  PubMed  CAS  Google Scholar 

  72. Hirschl MM, Seidler D, Müllner M, et al. Efficacy of different antihypertensive drugs in the emergency department. J Hum Hypertens 1996; 10 Suppl. 3: 143–6

    Google Scholar 

  73. Passmore J, Loomis JH. The role of IV enalaprilat in lowering blood pressure. Hosp Formul 1993; 28: 173–9

    Google Scholar 

  74. Smith Kline & French. Fenoldopam Working Group: Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. Cardiovasc Drugs Ther 1992; 6: 445–6

    Article  Google Scholar 

  75. Bodmann KF, Tröster S, Clemens R, et al. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis. Clin Invest 1993; 72: 60–4

    Article  CAS  Google Scholar 

  76. Frolich ED. American College of Chest Physicians’ Consensus Panel on Hypertensive Emergencies. Chest 1990 Oct; 98: 785–6

    Article  Google Scholar 

  77. Ram CVS. Immediate management of severe hypertension. Cardiol Clin 1995; 13: 579–91

    PubMed  CAS  Google Scholar 

  78. Dandapani BK, Suzuki S, Kelley RE, et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995; 26: 21–4

    Article  PubMed  CAS  Google Scholar 

  79. Lavin P. Management of hypertension in patients with acute stroke. Arch Intern Med 1986; 146: 66–8

    Article  PubMed  CAS  Google Scholar 

  80. Brott T, Reed RL. Intensive care for acute stroke in the community hospital setting. The first 24 hours. Stroke 1989; 20: 694–7

    Article  PubMed  CAS  Google Scholar 

  81. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17: 861–4

    Article  PubMed  CAS  Google Scholar 

  82. Rordorf G, Cramer SC, Efird JT, et al. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997; 28: 2133–8

    Article  PubMed  CAS  Google Scholar 

  83. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43: 461–7

    Article  PubMed  CAS  Google Scholar 

  84. The Sixth Report of the Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–46

    Article  Google Scholar 

  85. Gelmers HJ, Gorter K, de Weerdit CJ, et al. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 1988; 318: 203–7

    Article  PubMed  CAS  Google Scholar 

  86. Martinez-Vila E, Guillen F, Villanueva JA, et al. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke 1990; 21: 1023–8

    Article  PubMed  CAS  Google Scholar 

  87. Flaherty JT. Comparison of intravenous nitroglycerin and sodium nitroprusside in acute myocardial infarction. Am J Med 1983; 74 Suppl. 6B: 53–60

    Article  PubMed  CAS  Google Scholar 

  88. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 237: 248–54

    Article  Google Scholar 

  89. Phillips RA, Goldman ME, Ardeljan M, et al. Isolated T-wave abnormalities and evaluation of left ventricular wall motion after nifedipine for severe hypertension. Am J Hypertens 1991; 4: 432–7

    PubMed  CAS  Google Scholar 

  90. O’Mailia JJ, Sander GE, Giles TD. Nifedipine associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med 1987; 107: 185–6

    PubMed  Google Scholar 

  91. Lindheimer MD, Katz AI. Hypertension in pregnancy. N Engl J Med 1985; 313: 675–80

    Article  PubMed  CAS  Google Scholar 

  92. Grossman E, Messerli FH. High blood pressure: a side effect of drugs, poisons, and food. Arch Intern Med 1995; 155: 450–60

    Article  PubMed  CAS  Google Scholar 

  93. Gales MA. Oral antihypertensives for hypertensive urgencies. Ann Pharmacother 1994; 28: 352–8

    PubMed  CAS  Google Scholar 

  94. Biollaz J, Waeber B, Brunner HR. Hypertensive crisis treated with orally administered Captopril. Am J Clin Pharmacol 1983; 25: 145–9

    Article  CAS  Google Scholar 

  95. Case DB, Atlas SA, Sullivan PA, et al. Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor Captopril. Circulation 1981; 64: 765–71

    Article  PubMed  CAS  Google Scholar 

  96. Tschollar W, Belz GG. Sublingual Captopril in hypertensive crisis. Lancet 1985; I: 34–5

    Article  Google Scholar 

  97. Di Veroli C, Pastorelli R. Orally dissolved Captopril compared with Captopril in standard oral administration in the treatment of hypertensive emergencies and urgencies in the elderly. Curr Ther Res 1991; 50: 586–90

    Google Scholar 

  98. Angeli P, Chiesa M, Caregaro L, et al. Comparison of sublingual Captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med 1991; 151: 678–82

    Article  PubMed  CAS  Google Scholar 

  99. Pascale C, Zampaglione B, Marchisiti M. Management of hypertensive crisis: nifedipine in comparison with Captopril, Clonidine, and furosemide. Curr Ther Res 1992; 51: 9–18

    Google Scholar 

  100. Komsuoglu B, Sengun II, Bayram A. Treatment of hypertensive urgencies with oral nifedipine, nicardipine, and Captopril. Angiology 1991; 42: 447–54

    Article  PubMed  CAS  Google Scholar 

  101. Pastorelli R, Ferri C, Santucci A. New therapeutic possibilities in hypertensive emergencies. Curr Ther Res 1991; 50: 857–68

    Google Scholar 

  102. Ceyhan B, Karaaslan Y, Caymaz O, et al. Comparison of sub-lingual Captopril and sublingual nifedipine in hypertensive emergencies. Jpn J Pharmacol 1990; 52: 189–93

    Article  PubMed  CAS  Google Scholar 

  103. Just VL, Schrader BJ, Paloucek FP, et al. Evaluation of drug therapy for treatment of hypertensive urgencies in the emergency department. Am J Emerg Med 1991; 9: 107–11

    Article  PubMed  CAS  Google Scholar 

  104. Panlilio AG, Vilela GC, San Vicente FG. Randomized single-blind parallel study of the short-term blood pressure response to sublingual Clonidine and sublingual. Philipp J Int Med 1990; 28: 447–56

    Google Scholar 

  105. Rohr G, Reimnitz P, Blanke P. Treatment of hypertensive emergency: comparison of a new dosage form of the calcium antagonist nitrendipine with nifedipine capsules. Intensive Care Med 1994; 20: 268–71

    Article  PubMed  CAS  Google Scholar 

  106. Savi L, Montebelli MR, D’Alonzo S. Sublingual nicardipine versus nifedipine to treat hypertensive urgencies. Int J Clin Pharmacol Ther Toxicol 1992; 30: 41–5

    PubMed  CAS  Google Scholar 

  107. Karachalios GN, Chrisikos N, Kintziou H, et al. Treatment of hypertensive crisis with sublingual Captopril. Curr Ther Res 1990; 48: 5–9

    Google Scholar 

  108. Bauer JH, Reams GP. The role of calcium entry blockers in hypertensive emergencies. Circulation 1987; 75 Suppl. V: 174–80

    Google Scholar 

  109. Beer N, Gallegos I, Cohen A, et al. Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension. Chest 1981; 79: 571–4

    Article  PubMed  CAS  Google Scholar 

  110. Huysmans FTM, Sluiter HE, Thien TA, et al. Acute treatment of hypertensive crisis with nifedipine. Br J Clin Pharmacol 1983; 16: 725–7

    Article  PubMed  CAS  Google Scholar 

  111. Opie LH, Jennings A. Sublingual Captopril versus nifedipine in hypertensive crises [letter]. Lancet 1985; I: 555

    Article  Google Scholar 

  112. Frishman WH, Weinberg P, Peled HB, et al. Calcium entry blockers for the treatment of severe hypertension and hypertensive crisis. Am J Med 1984; 77(2B): 35–45

    PubMed  CAS  Google Scholar 

  113. Gambhir IS, Gupta SS, Singh DS. Sublingual nifedipine in hypertensive emergencies with special reference to cerebrovascular accident. J Indian Med Assoc 1991; 89: 231–4

    PubMed  CAS  Google Scholar 

  114. Abraham G, Shukkur A, Van Der Meulen J, et al. Sublingual nifedipine a safe and simple therapy for hypertensive emergencies. Br J Clin Pract 1986; 40: 478–81

    PubMed  CAS  Google Scholar 

  115. Houston MC. Treatment of hypertensive urgencies and emergencies with nifedipine. Am Heart J 1986; 111: 963–9

    Article  PubMed  CAS  Google Scholar 

  116. Dadkar VN, Karnik ND, Izar M, et al. Sublingual nifedipine and Captopril in hypertensive urgencies and emergencies. Indian Heart J 1993; 45: 185–7

    PubMed  CAS  Google Scholar 

  117. Wu SG, Lin SL, Shiao WY, et al. Comparison of sublingual Captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis. Nephron 1993; 65: 284–7

    Article  PubMed  CAS  Google Scholar 

  118. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. Am J Obstet Gynecol 1993; 169: 960–4

    PubMed  CAS  Google Scholar 

  119. Kumar N, Batra YK, Bala I, et al. Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy induced hypertension. Can J Anaesth 1993; 40: 329–33

    Article  PubMed  CAS  Google Scholar 

  120. Hasdai D. Sublingual Captopril and nifedipine in immediate treatment of hypertensive emergencies. Arch Intern Med 1992; 152: 1725–6

    Article  PubMed  CAS  Google Scholar 

  121. Opie LH. Sublingual nifedipine [letter]. Lancet 1991; 338: 1203

    Article  PubMed  CAS  Google Scholar 

  122. Gonzalez Carmona VM, Ibarra Perez C, Jerjes Sanchez C. Single dose sublingual nifedipine as the only treatment in hypertensive urgencies and emergencies. Angiology 1991; 42: 908–13

    Article  PubMed  CAS  Google Scholar 

  123. Angeli P, Chiesa M, Caregaro L, et al. Comparison of sublingual Captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med 1991; 151: 678–82

    Article  PubMed  CAS  Google Scholar 

  124. Lopez Herce J, Dorao P, de la Oliva P, et al. Dosage of nifedipine in hypertensive crises of infants and children. Eur J Pediatr 1989; 149: 136–7

    Article  PubMed  CAS  Google Scholar 

  125. Hatton RC, Marcadis ML. Sublingual nifedipine in acute severe hypertension [letter]. Arch Dis Child 1989; 64(4): 633

    Article  PubMed  CAS  Google Scholar 

  126. Wells DG, Davies GG, Rosewarne F. Attenuation of electroconvulsive therapy induced hypertension with sublingual nifedipine. Anaesth Intensive Care 1989; 17: 31–3

    PubMed  CAS  Google Scholar 

  127. Schenk CH, Remick RA. Sublingual nifedipine in the treatment of hypertensive crisis associated with monoamine oxidase inhibitors. Ann Emerg Med 1989; 18: 114–5

    Article  PubMed  CAS  Google Scholar 

  128. Spah F, Grosser KD. Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and Clonidine: effect on blood pressure and heart rate. J Cardiovasc Pharmacol 1988; 12 Suppl. 4: S154–6

    Article  PubMed  Google Scholar 

  129. Dire DJ, Kuhns DW. The use of sublingual nifedipine in a patient with a Clonidine overdose. J Emerg Med 1988; 6: 125–8

    Article  PubMed  CAS  Google Scholar 

  130. Evans JH, Shaw NJ, Brocklebank JT. Sublingual nifedipine in acute severe hypertension. Arch Dis Child 1988; 63: 975–7

    Article  PubMed  CAS  Google Scholar 

  131. Lopez Herce J, Albajara L, Cagigas P, et al. Treatment of hypertensive crisis in children with nifedipine. Intensive Care Med 1988; 14: 519–21

    Article  PubMed  CAS  Google Scholar 

  132. Karachalios GN, Donas G, Tsimiklis S, et al. Treatment of hypertensive emergencies with nifedipine. Int J Clin Pharmacol Ther Toxicol 1988; 26: 351–5

    PubMed  CAS  Google Scholar 

  133. Schillinger D. Nifedipine in hypertensive emergencies: a prospective study. J Emerg Med 1987; 5: 463–73

    Article  PubMed  CAS  Google Scholar 

  134. Puri GD, Batra YK, Singh H. Efficacy of sublingual nifedipine in the relief of immediate post-operative hypertension. Indian J Med Res 1987; 86: 624–8

    PubMed  CAS  Google Scholar 

  135. Singh NK, Avasthey P, Kapoor JP Sublingual nifedipine therapy in accelerated hypertension and acute cardiac ischaemia. J Assoc Physicians India 1987; 35: 465–6

    PubMed  CAS  Google Scholar 

  136. Mohanan PP, Visweswaran RK. Sublingual nifedipine in severe hypertension with advanced renal failure. J Assoc Physicians India 1987; 35: 222–3

    PubMed  CAS  Google Scholar 

  137. Gibson RG, Oliver JA, Leak D. Nifedipine therapy of phenylpropanolamine-induced hypertension. Am Heart J 1987; 113: 406–7

    Article  PubMed  CAS  Google Scholar 

  138. Franklin C, Nightingale S, Mamdani B. Arandomized comparison of nifedipine and sodium nitroprusside in severe hypertension. Chest 1986; 90: 500–3

    Article  PubMed  CAS  Google Scholar 

  139. Lo Cicero G, Binaghi P, Cellina G, et al. Sublingual nifedipine. A new approach to the therapy of hypertensive crisis in pregnancy. Minerva Ginecol 1986; 38: 631–5

    PubMed  Google Scholar 

  140. Ellrodt AG, Ault MJ, Riedinger MS, et al. Efficacy and safety of sublingual nifedipine in hypertensive emergencies. Am J Med 1985; 79: 19–25

    Article  PubMed  CAS  Google Scholar 

  141. Haft JI, Litterer WE III. Chewing nifedipine to rapidly treat hypertension. Arch Intern Med 1984; 144: 2357–9

    Article  PubMed  CAS  Google Scholar 

  142. Erbel R, Brand G, Meyer J, et al. Emergency treatment of hypertensive crisis with sublingual nifedipine. Postgrad Med J 1983; 59 Suppl. 3: 134–6

    PubMed  Google Scholar 

  143. Adler A, Leahy JJ, Cressman MD. Management of perioperative hypertension using sublingual nifedipine, experience in elderly patients undergoing eye surgery. Arch Intern Med 1986; 46: 1927–30

    Article  Google Scholar 

  144. Vukich DJ, Fluskey LL, McPherson JR. The prehospital use of sublingual nifedipine in hypertensive urgencies and emergencies [letter]. Ann Emerg Med 1990; 19: 459

    Google Scholar 

  145. Kürkciyan I, Sterz F, Roden M, et al. A new preparation of nifedipine for sublingual application in hypertensive urgencies. Angiology 1994; 45: 629–35

    Article  PubMed  Google Scholar 

  146. Komsuoglu SS, Komsuoglu B, Ozmenoglu M, et al. Oral nifedipine in the treatment of hypertensive crises in patients with hypertensive encephalopathy, Int J Cardiol 1992; 34: 277–82

    Article  PubMed  CAS  Google Scholar 

  147. Phillips RA. Nifedipine and hypertensive urgencies. Emerg Med 1990; 22: 91–100

    Google Scholar 

  148. Erne P, Bolli P, Bertel O, et al. Factors influencing the hypotensive effects of calcium antagonists. Hypertension 1983; 5: 1197–102

    Google Scholar 

  149. Taburet AM, Singlas E, Colin JN, et al. Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects. Hypertension 1983; 5: 1129–33

    Google Scholar 

  150. McAllister RG. Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med 1986; 81 Suppl. 6A: 2–5

    Article  PubMed  CAS  Google Scholar 

  151. van Harten J, Burggraaf K, Danhof M, et al. Negligible sublingual absorption of nifedipine. Lancet 1987; II: 1363–5

    Article  Google Scholar 

  152. Schumann D. Sublingual nifedipine controversy in drug delivery. Dimens Crit Care Nurs 1991; 10: 314–20

    Article  PubMed  CAS  Google Scholar 

  153. Diker E, Erturk S, Akgun G. Is sublingual nifedipine administration superior to oral administration in the active treatment of hypertension? Angiology 1992; 43: 477–81

    Article  PubMed  CAS  Google Scholar 

  154. Grossman E, Messerli FH, Grodzicki T, et al. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996; 276: 1328–31

    Article  PubMed  CAS  Google Scholar 

  155. Dalence W, Sosa L, Gonzales R. Sublingual nifedipine in hypertensive crisis: relationship between mean arterial pressure and cerebral blood flow. Curr Ther Res 1991; 49: 290–5

    Google Scholar 

  156. Nobile-Orazio E, Sterzi R. Cerebral ischaemia after nifedipine treatment. BMJ 1981; 283: 948

    Article  PubMed  CAS  Google Scholar 

  157. Schwartz M, Naschitz JE, Yeshurun D, et al. Oral nifedipine in the treatment of hypertensive urgency: cerbrovascular accident following a single dose. Arch Intern Med 1990; 150: 686–7

    Article  PubMed  CAS  Google Scholar 

  158. Wachter RM. Symptomatic hypotension induced by nifedipine in the acute treatment of severe hypertension. Arch Intern Med 1987; 147: 556–8

    Article  PubMed  CAS  Google Scholar 

  159. Zangerle KF, Wolford R. Syncope and conduction disturbances following sublingual nifedipine for hypertension. Ann Emerg Med 1985; 14: 1005–6

    Article  PubMed  CAS  Google Scholar 

  160. Leavitt AD, Zweifler AJ. Nifedipine, hypotension and myocardial injury [letter]. Ann Intern Med 1988; 108: 305

    Google Scholar 

  161. Shettigar UR, Loungani R. Adverse effects of sublingual nifedipine in acute myocardial infarction. Crit Care Med 1989; 17: 196–7

    Article  PubMed  CAS  Google Scholar 

  162. Cheng TO. Adverse effects of sublingual nifedipine in acute myocardial infarction [letter]. Crit Care Med 1989; 17: 1364

    Article  PubMed  CAS  Google Scholar 

  163. Aromatorio GJ, Uretsky BF, Reddy PS. Hypotension and sinus arrest with nifedipine in pulmonary hypertension. Chest 1985; 87: 265–7

    Article  PubMed  CAS  Google Scholar 

  164. Impey L. Severe hypotension and fetal distress following sub-lingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993; 100: 959–61

    Article  PubMed  CAS  Google Scholar 

  165. Saborowski F, Schwendler-Haffke E, Blanke P. Efficacy and tolerability of the liquid formulation of nitrendipine in the treatment of hypertensive emergency. Eur J Clin Res 1996; 8: 75–85

    Google Scholar 

  166. Habib GB, Dunbar LM, Rodrigues R. Evaluation of the efficacy and safety of oral nicardipine in treatment of urgent hypertension: a multicenter, randomized, double-blind, parallel, placebo-controlled clinical trial. Am Heart J 1995; 129: 917–23

    Article  PubMed  CAS  Google Scholar 

  167. Ram CVS. Nicardipine for systemic hypertension: effects on blood pressure and target organ function. Am J Cardiol 1987; 59: 25J–30J

    Article  PubMed  CAS  Google Scholar 

  168. Saragoca MA, Portela JE, Plavnik F, et al. Isradipine in the treatment of hypertensive crisis in ambulatory patients. J Cardiovasc Pharmacol 1992; 19 Suppl. 3: S76–S78

    PubMed  Google Scholar 

  169. Cohen IM, Katz MA. Oral Clonidine loading for rapid control of hypertension. Clin Pharmacol Ther 1978; 24: 11–5

    PubMed  CAS  Google Scholar 

  170. Karachalios GN. Hypertensive emergencies treated with oral Clonidine. Eur J Clin Pharmacol 1990; 31: 227–9

    Article  Google Scholar 

  171. Jaker M, Atkin S, Soto M, et al. Oral nifedipine vs oral Clonidine in the treatment of urgent hypertension. Arch Intern Med 1989; 149: 260–5

    Article  PubMed  CAS  Google Scholar 

  172. Anderson RJ, Hart GR, Crumpler CP, et al. Oral Clonidine loading in hypertensive urgencies. JAMA 1981; 246: 848–50

    Article  PubMed  CAS  Google Scholar 

  173. Spitalewitz S, Porush JG, Oguagha C. Use of oral Clonidine for rapid titration of blood pressure in severe hypertension. Chest 1983; 83 Suppl: 404–7

    PubMed  CAS  Google Scholar 

  174. Lowenthal DT, Matzed KM, MacGregor TR. Clinical pharmacokinetics of Clonidine. Clin Pharmacokinet 1988; 14: 287–310

    Article  PubMed  CAS  Google Scholar 

  175. Gonzalez ER, Peterson MA, Rachi EM. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension. Ann Emerg Med 1991 Apr; 20: 333–8

    Article  PubMed  CAS  Google Scholar 

  176. Atkin SH, Jaker MA, Beaty P, et al. Oral labetalol versus oral Clonidine in the emergency treatment of severe hypertension. Am J Med Sci 1992; 303: 9–15

    Article  PubMed  CAS  Google Scholar 

  177. Hayes JM. Prazosin in severe hypertension. Effect on blood pressure, plasma renin activity and in hypertensive emergencies. Med J Aust 1977; 2 Suppl: 30–2

    PubMed  CAS  Google Scholar 

  178. White WB, Baker LH. Ambulatory blood pressure monitoring in patients with panic disorder. Arch Intern Med 1987; 147: 1973–5

    Article  PubMed  CAS  Google Scholar 

  179. Groshong T. Hypertensive crisis in children. Pediatr Ann 1996; 23: 368–79

    Google Scholar 

  180. Messerli FH, Ventura HO, Glade LB, et al. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983; 2: 983–5

    Article  PubMed  CAS  Google Scholar 

  181. Thacker HL, Jahnigen DW. Cardiology — managing hypertensive emergencies and urgencies in the geriatric patient. Geriatrics 1991; 46: 26–37

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Mediane D, The Chaim Sheba Medical Center, Tel-Hashomer, 52621, Israel

    Ehud Grossman & Avi N. Ironi

  2. Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic, USA

    Franz H. Messerli

  3. Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA

    Franz H. Messerli

Authors
  1. Ehud Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Avi N. Ironi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franz H. Messerli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossman, E., Ironi, A.N. & Messerli, F.H. Comparative Tolerability Profile of Hypertensive Crisis Treatments. Drug-Safety 19, 99–122 (1998). https://doi.org/10.2165/00002018-199819020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199819020-00003

Keywords

Search

Navigation